2,459
Views
25
CrossRef citations to date
0
Altmetric
Case Report

Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine

ORCID Icon, , &
Pages 4093-4096 | Received 03 Jun 2021, Accepted 06 Jul 2021, Published online: 04 Aug 2021

References

  • Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). In StatPearls. Treasure Island, FL: StatPearls Publishing; 2020 [accessed 2021 May 25]. http://www.ncbi.nlm.nih.gov/books/NBK554776/
  • Espinosa PS, Rizvi Z, Sharma P, Hindi F, Filatov A. Neurological complications of coronavirus disease (COVID- 19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2. Cureus. 2020;12:e7930.
  • Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID- 19): encephalopathy. Cureus. 2020;12:e7352.
  • Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med. 2021;27:205–11. doi:10.1038/s41591-021-01230-y.
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;31:2603–15. doi:10.1056/NEJMoa2034577.
  • Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological Complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureu.s. 2021;13:e13426.
  • Dengler R, de Carvalho M, Shahrizaila N, Nodera H, Vucic S, Grimm A, Padua L, Schreiber S, Kneiser MK, Hobson‐Webb LD, et al. AANEM-IFCNGlossary of terms in neuromuscular electrodiagnostic medicine and ultrasound. Muscle Nerve. 2020;62:10–12. doi:10.1002/mus.26868.
  • Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain J Neurol. 2002;125(Pt 12):2591–625. doi:10.1093/brain/awf272.
  • Kusunoki S. Anti-ganglioside antibodies in Guillain-Barré syndrome; useful diagnostic markers as well as possible pathogenetic factors. Intern Med. 2003;42(6):457–58. doi:10.2169/internalmedicine.42.457.
  • Ho TW, Hsieh ST, Nachamkin I, Willison HJ, Sheikh K, Kiehlbauch J, Flanigan K, McArthur JC, Cornblath DR, McKhann GM, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology. 1997;48(3):717–24. doi:10.1212/WNL.48.3.717.
  • Drugs and lactation database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006 [ Updated 2021 May 17]. COVID-19 vaccines.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.